Secretary for Health Prof Lo Chung-mau met a delegation led by Guangdong Provincial Medical Products Administration (GDMPA) General Director Jiang Xiaodong today, with both sides agreeing to further deepen collaboration in relevant areas. Prof Lo said the Hong Kong Special Administrative Region Government expressed its sincere gratitude to the GDMPA for its staunch support for Hong Kong in the past, including the implementation of the initiatives of, among others, the measure of using Hong Kong registered drugs and medical devices used in Hong Kong public hospitals in the Guangdong-Hong Kong-Macao Greater Bay Area and streamlining of the approval procedures for Hong Kong registered traditional proprietary Chinese medicines (pCms) for external use to be registered and sold in the Mainland. The Government and the GDMPA agreed at the meeting to further deepen collaboration on the regulation of Chinese medicines (CM), the formulation of Greater Bay Area Chinese medicine standards,
The Department of Health said that in the preceding week ending August 8, it received 193 reports of adverse events following COVID-19 immunisation.
Among them, no death case was reported by the Hospital Authority involving individuals who had received vaccines within 14 days before they died and had potential association with vaccination.
As at 8pm on August 8, more than 6.18 million doses of COVID-19 vaccines had been administered to the public.
The department received 4,927 reports of adverse events, 30 of which are death cases with vaccination within 14 days. The figures represented 0.08% and 0.0005% of the total vaccine doses administered. None of the death cases was associated with vaccination.
As of August 8, the Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation concluded that 18 death cases had no causal relationship with vaccination, and preliminarily considered that nine cases were not associated with vaccination. Three other cases were pending assessment.
The committee considered that there is no unusual pattern identified so far, and will continue to closely monitor the situation and collect data for assessment.
According to information from the authority, during the period from July 12 to August 8, the ratio of death cases out of those without a vaccination record was 81.5 cases for every 100,000 people, whereas the ratio of death cases for those with a vaccination record was 2.7 cases for every 100,000 people. The overall death rate is similar to that recorded in the past three years.
Out of those without a vaccination record, the ratio of death cases with acute stroke or acute myocardial infarction was 3.9 cases for every 100,000 people, whereas the ratio of death cases under the same category for those with a vaccination record was 0.2 cases for every 100,000 people.
Furthermore, the ratio of miscarriage cases out of those without a vaccination record was 32.8 cases for every 100,000 people, whereas the ratio of miscarriage cases for those who had a vaccination record was seven cases for every 100,000 people.
Based on the statistical analysis of the above figures, there is no evidence that vaccination increases the risk of death or miscarriage for recipients.
The relevant reference statistics will be uploaded to the COVID-19 Vaccination Programme thematic website.
The majority of non-death cases of adverse events received so far are relatively minor ones, details of which can be found here.
http://dlvr.it/S5STlb
http://dlvr.it/S5STlb